| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 05/06/2009 | CN100484932C Method for synthesizing 2-thenoic acetate by thiophene |
| 05/05/2009 | US7528289 Isoparaffin-olefin alkylation |
| 05/05/2009 | US7528261 Small molecule compound having indolocarbazole moiety and divalent linkage |
| 05/05/2009 | US7528154 Polyarylcarboxamides useful as lipid lowering agents |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 04/30/2009 | WO2009055734A1 Condensed compounds with activity at estrogen receptors |
| 04/30/2009 | WO2009055519A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009055516A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009053697A1 Polymorphic forms of ( s ) -rotigotine hydrochloride |
| 04/30/2009 | WO2006014405A3 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 04/30/2009 | US20090112001 Optically active methylhydroxylaminopropanol derivative and its use as intermediate for preparation of (s)-(-)-3-methylamino-1-(2-thienyl)propan-1-ol |
| 04/30/2009 | US20090112000 Methylhydroxylaminopropanol derivative and its use as intermediate for preparation of 3-methylamino-1-(2-thienyl)propan-1-ol |
| 04/30/2009 | CA2704040A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2703717A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2700210A1 Condensed compounds with activity at estrogen receptors |
| 04/29/2009 | EP2051974A1 Tetrahydrobenzothiophene derivatives |
| 04/29/2009 | EP2051709A2 Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque |
| 04/29/2009 | EP2051707A2 Inhibitors of plasma kallikrein |
| 04/29/2009 | EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421258A Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 04/29/2009 | CN101421230A Novel phenyl-propargylether derivatives |
| 04/29/2009 | CN100482644C Chiral diene ligand, synthesis method and its application in asymmetric reaction |
| 04/29/2009 | CN100482639C N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524973 4-Nitrooxybutyl 4-(2,6-Dichlorophenylamino)-thiophen-3-ylacetate; cytoprotective nitric oxide releasing nonsteroidal antiinflammatory agents; cyclooxygenase inhibitors; reduced side effects |
| 04/28/2009 | US7524922 Poly(benzodithiophenes) |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009052191A1 Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 04/23/2009 | WO2009051390A2 Novel thiophene-based dye and preparation thereof |
| 04/23/2009 | WO2009051088A1 Sulfone compound, sulfonic acid salt, and radiation-sensitive resin composition |
| 04/23/2009 | WO2009050037A1 Metallocene compounds based on ethanediyl-bridged indene and cyclopentadithiophene ligands |
| 04/23/2009 | WO2009049362A1 A1 adenosine receptor allosteric enhancers |
| 04/23/2009 | WO2009017719A3 Modulators of ccr9 receptor and methods of use thereof |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | US20090105315 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists |
| 04/23/2009 | US20090105308 Benzoheterocylethylcarboxamide derivatives |
| 04/23/2009 | US20090105280 Novel Aromatic Nitro Compounds |
| 04/23/2009 | US20090105259 Acyclic 1,4-Diamines and Uses Thereof |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105241 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 04/23/2009 | US20090105222 Prevention and treatment of functional somatic disorders, including stress-related disorders |
| 04/22/2009 | EP2049512A2 Crystalline duloxetine hydrochloride |
| 04/22/2009 | EP1851193B1 Hiv protease inhibitors |
| 04/22/2009 | EP1500432B1 Method for oxidizing alcohol on a ruthenium-carrying alumina catalyst |
| 04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 04/22/2009 | CN101415670A Methods for preparing sulfonamide substituted alcohols and intermediates thereof |
| 04/22/2009 | CN101412708A Duloxetine derivative and preparation thereof |
| 04/22/2009 | CN101412707A Duloxetine derivative and preparation thereof |
| 04/21/2009 | US7521480 Such as 2-[3-(3-Bromo-phenyl)-ureido]-4-chloro-5-methyl-benzenesulfonic acid which is selective and non-competitive antagonist of ionotropic GluR5 receptor |
| 04/21/2009 | US7521473 Inhibitors of protein tyrosine phosphatase 1B |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | WO2009048152A2 Unsaturated imine compound and use thereof for pest control |
| 04/16/2009 | WO2009047615A2 Novel histone deacetylase inhibitors |
| 04/16/2009 | WO2009047568A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
| 04/16/2009 | WO2009047152A1 Sulphonium salt initiators |
| 04/16/2009 | WO2009047105A1 Sulphonium salt initiators |
| 04/16/2009 | WO2009006066A3 Process for the preparation of benzimidazol thienylamine compounds and intermediates thereof |
| 04/16/2009 | WO2006078813A3 Arginine analogs, and methods for their synthesis and use |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/16/2009 | US20090099250 Benzocycloheptene derivatives as estrogens having selective activity |
| 04/16/2009 | US20090099239 Antiviral Compounds and Methods |
| 04/16/2009 | US20090099204 Amide derivative, insecticide containing the same and method for application thereof as insecticide |
| 04/16/2009 | US20090099147 Non-steroidal progesterone receptor modulators |
| 04/16/2009 | CA2702536A1 Novel histone deacetylase inhibitors |
| 04/16/2009 | CA2702182A1 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
| 04/16/2009 | CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/15/2009 | EP2046789A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 04/15/2009 | EP2046772A1 Thiophenemethyl salicylate and related compounds as flavours and fragrances |
| 04/15/2009 | EP2046748A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 04/15/2009 | EP2046714A2 Therapeutic compounds |
| 04/15/2009 | EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/15/2009 | EP1432680B1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 04/15/2009 | EP1386663B1 Microencapsulated metal catalyst |
| 04/15/2009 | CN101410386A 2-alkenyl-3-aminothiophene derivative and process for producing thereof |
| 04/15/2009 | CN101407510A Preparation of duloxetine hydrochloride intermediate |
| 04/14/2009 | US7517992 (-)-cis-1-(5-(4-fluorophenoxy)-pyridin-2-yl)-3-(4,7-difluoro-1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea; improved resistance and pharmacokinetic profile; polymerase inhibitors; potent against virus comprising drug escape mutations |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/14/2009 | US7517880 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 04/14/2009 | US7517879 Pyrrolidine derivatives as factor Xa inhibitors |
| 04/14/2009 | CA2253211C Sulfonamide-substituted fused 5-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
| 04/14/2009 | CA2170479C Benzothiophene compounds, intermediates, compositions, and methods |
| 04/09/2009 | WO2009044311A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 04/09/2009 | WO2008121592A3 Acetyl coenzyme a carboxylase inhibitors |
| 04/09/2009 | US20090093645 Synthesis and preparations of duloxetine salts |
| 04/09/2009 | US20090093530 (2R)-2-[4-Sulfonyl) Aminophenyl] Propanamides and Pharmaceutical Compositions Containing Them |
| 04/09/2009 | US20090091244 Amine compound, organic light-emitting device, and organic blue-light-emitting device |
| 04/09/2009 | CA2701768A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 04/08/2009 | EP2044049A2 Process for the preparation of enantiomerically pure salts of n-methyl- 3 -( 1-naph-thaleneoxy)- 3 - (-2-thienyl) propanamine |
| 04/08/2009 | EP2044016A2 4-heteroaryl-substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having effects on the opiod receptor system |